Search research articles
Contact Us
Filters
Showing results (11-20 of 30) with videos related to
Page
of 3
Sort By:
The Journal of Allergy and Clinical Immunology
|
August 23, 2021
Defining baseline variability of serum tryptase levels improves accuracy in identifying anaphylaxis
Allyson Mateja, Qinlu Wang, Jack Chovanec, et al.
The Journal of Infectious Diseases
|
March 23, 2021
Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses
Joshua G Petrie, Latifa A Bazzi, Adrian B McDermott, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 19, 2024
Durability of Protection Against COVID-19 Through the Delta Surge for the NVX-CoV2373 Vaccine
Dean Follmann, Allyson Mateja, Michael P Fay, et al.
Allergy
|
January 13, 2025
Evaluation of Intestinal Permeability Using Serum Biomarkers in Learning Early About Peanut Allergy Trial
Ozge Nur Aktas, Allyson Mateja, Min Jenny Li, et al.
Research Square
|
May 7, 2026
Humoral Immune Correlates Analysis of Four Vaccines Against SARS-CoV-2 in Rhesus Macaques
Michael Fay, Allyson Mateja, Chris Cirimotich, et al.
Mbio
|
January 9, 2024
Mucosal correlates of protection after influenza viral challenge of vaccinated and unvaccinated healthy volunteers
Rachel Bean, Luca T Giurgea, Alison Han, et al.
The New England Journal of Medicine
|
May 3, 2023
Reappraisal of Idiopathic CD4 Lymphocytopenia at 30 Years
Andrea Lisco, Ana M Ortega-Villa, Harry Mystakelis, et al.
Ebiomedicine
|
November 27, 2022
Safety and immunogenicity of AGS-v PLUS, a mosquito saliva peptide vaccine against arboviral diseases: A randomized, double-blind, placebo-controlled Phase 1 trial
DeAnna J Friedman-Klabanoff, Megan Birkhold, Mara T Short, et al.
The Journal of Infectious Diseases
|
October 31, 2021
Development of Inapparent Dengue Associated With Increased Antibody Levels to Aedes aegypti Salivary Proteins: A Longitudinal Dengue Cohort in Cambodia
Jessica E Manning, Sophana Chea, Daniel M Parker, et al.
Lancet (London, England)
|
June 15, 2020
Safety and immunogenicity of a mosquito saliva peptide-based vaccine: a randomised, placebo-controlled, double-blind, phase 1 trial
Jessica E Manning, Fabiano Oliveira, Iliano V Coutinho-Abreu, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 30) with videos related to
Sort By:
Page
of 3
The Journal of Allergy and Clinical Immunology
|
August 23, 2021
Defining baseline variability of serum tryptase levels improves accuracy in identifying anaphylaxis
Allyson Mateja, Qinlu Wang, Jack Chovanec, et al.
The Journal of Infectious Diseases
|
March 23, 2021
Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses
Joshua G Petrie, Latifa A Bazzi, Adrian B McDermott, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 19, 2024
Durability of Protection Against COVID-19 Through the Delta Surge for the NVX-CoV2373 Vaccine
Dean Follmann, Allyson Mateja, Michael P Fay, et al.
Allergy
|
January 13, 2025
Evaluation of Intestinal Permeability Using Serum Biomarkers in Learning Early About Peanut Allergy Trial
Ozge Nur Aktas, Allyson Mateja, Min Jenny Li, et al.
Research Square
|
May 7, 2026
Humoral Immune Correlates Analysis of Four Vaccines Against SARS-CoV-2 in Rhesus Macaques
Michael Fay, Allyson Mateja, Chris Cirimotich, et al.
Mbio
|
January 9, 2024
Mucosal correlates of protection after influenza viral challenge of vaccinated and unvaccinated healthy volunteers
Rachel Bean, Luca T Giurgea, Alison Han, et al.
The New England Journal of Medicine
|
May 3, 2023
Reappraisal of Idiopathic CD4 Lymphocytopenia at 30 Years
Andrea Lisco, Ana M Ortega-Villa, Harry Mystakelis, et al.
Ebiomedicine
|
November 27, 2022
Safety and immunogenicity of AGS-v PLUS, a mosquito saliva peptide vaccine against arboviral diseases: A randomized, double-blind, placebo-controlled Phase 1 trial
DeAnna J Friedman-Klabanoff, Megan Birkhold, Mara T Short, et al.
The Journal of Infectious Diseases
|
October 31, 2021
Development of Inapparent Dengue Associated With Increased Antibody Levels to Aedes aegypti Salivary Proteins: A Longitudinal Dengue Cohort in Cambodia
Jessica E Manning, Sophana Chea, Daniel M Parker, et al.
Lancet (London, England)
|
June 15, 2020
Safety and immunogenicity of a mosquito saliva peptide-based vaccine: a randomised, placebo-controlled, double-blind, phase 1 trial
Jessica E Manning, Fabiano Oliveira, Iliano V Coutinho-Abreu, et al.
Page
of 3